BiographyAlexa Boer Kimball, MD, MPH, is an experienced and accomplished academic investigator, leader and administrator. She is currently Medical Director and Senior Vice President of the Massachusetts General Physician Organization, which employs more than 2000 physicians. A Professor of Dermatology at Harvard Medical School, she leads the Clinical Unit for Research Trials and Outcomes in Skin at Massachusetts General Hospital (MGH), and conducts 10-20 studies annually. Dr. Kimball?s areas of research include psoriasis and hidradenitis suppurativa. She has published over 250 papers, is the author of the book "101 Questions and Answers about Psoriasis," which has been translated into Spanish, Greek, and Korean, and editor of "Dermatologic Diseases and Cumulative Life Course Impairment." Dr. Kimball is widely recognized for her research on physician workforce economics, quality of life, and outcomes, for which she was recently awarded the American Skin Association Research Award for Health Policy and Medical Education and the MGH Bowditch Prize for increasing quality of care at the hospital while reducing costs. Dr. Kimball received her medical degree from the Yale University School of Medicine and her MPH from the Johns Hopkins School of Public Health, with dual bachelor's degrees in molecular biology and public and international affairs from Princeton University. She completed her residency in dermatology at the Stanford University Medical Center and a clinical research fellowship at the National Institutes of Health. Dr. Kimball also serves on multiple non-profit Boards including: the Society for Investigative Dermatology, where she was also elected Vice President, the Massachusetts Foundation for the Humanities and Public Policy, and the Hidradenitis Suppurativa Foundation. She is incoming President of the International Psoriasis Council and actively involved in the philanthropic campaigns of these and other non-profit scientific and medical organizations.
ResearchAlexa B. Kimball, MD, MPH is the director of the Clinical Unit for Research Trials and Outcomes in Skin (CURTIS). This unit conducts a wide variety of studies from industry-sponsored to physician-initiated Phase 1-4 trials evaluating new therapies and devices for a broad spectrum of skin diseases.
Currently, Dr. Kimball is actively conducting several dermatology studies, including therapies for hidradenitis suppurativa, psoriasis, and acne.
For more information, please e-mail firstname.lastname@example.org or call (617) 726-5066.
Selected Recent Publications:
1: Kimball AB, Sobell JM, Zouboulis CC, Gu Y, Williams DA, Sundaram M, Teixeira HD, Jemec GB. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study. J Eur Acad Dermatol Venereol. 2015 Jul 22. [Epub ahead of print]
2: Percac-Lima S, Cronin PR, Ryan DP, Chabner BA, Daly EA, Kimball AB. Patient navigation based on predictive modeling decreases no-show rates in cancer care. Cancer. 2015 May 15;121(10):1662-70.
3: Kim GE, Seidler E, Kimball AB. Effect of Age at Diagnosis on Chronic Quality of Life and Long-Term Outcomes of Individuals with Psoriasis. Pediatr Dermatol. 2014 Dec 29. doi: 10.1111/pde.12416. [Epub ahead of print]
4: Pascoe VL, Enamandram M, Corey KC, Cheng CE, Javorsky EJ, Sung SM, Donahue KR, Kimball AB. Using the Physician Global Assessment in a clinical setting to measure and track patient outcomes. JAMA Dermatol. 2015 Apr;151(4):375-81.
Browse the latest local and national news articles featuring stories from basic research to innovative breakthroughs in cosmetic dermatology.
Alexa Kimball, MD, MPH, medical director of the MGPO, received the 2014 Nathaniel Bowditch Prize on April 29.